Skip to main content

Myobloc FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 23, 2020.

FDA Approved: Yes (First approved December 8, 2000)
Brand name: Myobloc
Generic name: rimabotulinumtoxinB
Dosage form: Injection
Company: US WorldMeds, LLC
Treatment for: Cervical Dystonia, Sialorrhea

Myobloc (rimabotulinumtoxinB) is an acetylcholine release inhibitor indicated for the treatment of cervical dystonia and chronic sialorrhea.

Development timeline for Myobloc

Aug 26, 2019Approval FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.